ISSAR’S purpose lies in the development of new technologies at an affordable price to improve quality of life for Indian population. With over 25 years of experience and prime focus in Research and Development, ISSAR’S dedicated team of experts are proud to have developed India’s first ever peptide molecule, Melgain for the treatment of Vitiligo in 2004, which is now introduced as Novoskin® with improved properties and effectiveness. ISSAR’S commitment has also led to the development of their second New Chemical Entity called Xylentra®, which is the first ever peptide drug in the world for the treatment of burn wounds and microbial infections.Recently, ISSAR has also developed molecules for prevalent conditions in the Western world such as Inflammatory Bowel Diseases (IBD), Psoriasis and Sepsis.